How to find data

Select the required Time Period using the filter above
Choose the Commodity you need using the search bar or navigation tree (6,000+ items)
Select the Reporter, Partner and Trade Flow you want
Choose the visualization type
Customize your table or chart using the Settings button
Save your results as an image or data file using the Download button

India | Imports and Exports | World | Medicaments (excluding goods of heading 3002, 3005 or 3006) for therapeutic or prophylactic uses, put up in measured doses or in forms or packings for retail sale | Value (US$) and Value Growth, YoY (%) | 2012 - 2023

TABLE

LINE

COLUMN

PIE

MAP

Settings

Save query

Download

PNG
JPG
SVG

XLSX
XLSX (flat table)
XLSX (time series)

The value of exports of commodity group 3004 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale" from India totalled $ 18.8 billion in 2023. Sales of commodity group 3004 from India went up by 7.88% compared to 2022: exports of commodity group 3004 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale" went up by $ 1.37 billion (cumulative exports of commodity group 3004 from India amounted $17.4 billion in 2022)

Exports of commodity group 3004 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale" amounted to 4.36% of total exports from India (cumulative merchandise exports from India totalled $ 431 billion in 2023). The share of commodity group 3004 in total exports from India increased by 0.509 p.p. compared to 2022 (it was 3.85% in 2022 and cumulative exports from India were equal to $ 452 billion).

Exports of commodity group 3004 amounted to 88% of total sales of group "" from India in 2023 (the value of exports of commodity group from India amounted to $21 billion in 2023). The share of exports of commodity group 3004 in sales of commodity group from India increased by 0.041 p.p. compared to 2022 (it was 88% in 2022, and exports of commodity group from India were $19.7 billion).

Exports | India | 3004

Export destinations of 3004 Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale from India

Open

Where does India export Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale?

Top export destinations of "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale" from India in 2023:

USA with a share of 38% (7.22 billion US$)
United Kingdom with a share of 3.18% (600 million US$)
South Africa with a share of 3.14% (592 million US$)
France with a share of 2.61% (492 million US$)
Australia with a share of 2.13% (402 million US$)
Canada with a share of 2.04% (385 million US$)
Brazil with a share of 2.01% (378 million US$)
Belgium with a share of 1.99% (375 million US$)
Nigeria with a share of 1.97% (372 million US$)
Netherlands with a share of 1.88% (354 million US$)

Exports structure of 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale - from India in 2023 represented by the following main commodity groups:

85% (16 billion US$): 300490 - Medicaments; consisting of mixed or unmixed products n.e.c. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale
6.33% (1.19 billion US$): 300420 - Medicaments cont. other antibiotics (excl. of 3004.10), put up in measured doses/forms/packings for retail sale
3.74% (704 million US$): 300410 - Medicaments cont. penicillins/derivatives thereof with a penicillanic acid structure/streptomycins/their derivatives, put up in measured doses/forms/packings for retail sale
1.4% (264 million US$): 300450 - Medicaments cont. vitamins/other products of 29.36 (excl. of 3004.10-3004.40), put up in measured doses/forms/packings for retail sale
0.777% (146 million US$): 300439 - Medicaments cont. hormones/other products of 29.37 but not cont. antibiotics, put up in measured doses/forms/packings for retail sale
0.718% (135 million US$): 300432 - Medicaments cont. corticosteroid hormones, their derivatives & structural analogues, put up in measured doses/forms/packings for retail sale
0.667% (125 million US$): 300431 - Medicaments cont. insulin, put up in measured doses/forms/packings for retail sale

The value of imports of commodity group 3004 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale" to India totalled $ 1.24 billion in 2023. Sales of commodity group 3004 to India went up by 10.4% compared to 2022: imports of commodity group 3004 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale" went up by $ 118 million (the value of imports of commodity group 3004 to India was equal to $1.12 billion in 2022)

Imports of commodity group 3004 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale" accounted for 0.185% of total import flow to India (in 2023, total imports to India amounted to $ 672 billion). The share of commodity group 3004 in total imports to India increased by 0.031 p.p. compared to 2022 (it was 0.153% in 2022 and cumulative imports to India were equal to $ 732 billion).

Imports of commodity group 3004 reached 47% of total imports of group "" to India in 2023 (imports of commodity group to India totalled $2.6 billion in 2023). The share of purchases of commodity group 3004 in total imports of commodity group to India increased by 6.58 p.p. compared to 2022 (it was 41% in 2022, and imports of commodity group to India accounted for $2.73 billion).

Imports | India | 3004

Sources of imports of 3004 Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale for India